These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17548385)

  • 41. Pay-for-performance programs in the United Kingdom.
    Tahrani AA; Varughese GI; Macleod AF
    N Engl J Med; 2006 Oct; 355(17):1832-3; author reply 1833. PubMed ID: 17073001
    [No Abstract]   [Full Text] [Related]  

  • 42. General practice and the Australian Government's National Health Reform Plan.
    Kidd MR
    Med J Aust; 2010 Jul; 193(2):71-4. PubMed ID: 20642405
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of practitioner education, practitioner payment and reimbursement of patients' drug costs on smoking cessation in primary care: a cluster randomised trial.
    Twardella D; Brenner H
    Tob Control; 2007 Feb; 16(1):15-21. PubMed ID: 17297068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eyes on the prize. Benchmarking, strong leadership help Delaware's family practice associates reap financial rewards for managing chronic conditions.
    Lewis M
    Med Econ; 2011 Feb; 88(3):34, 36-8, 41-2. PubMed ID: 21800512
    [No Abstract]   [Full Text] [Related]  

  • 45. Rethinking diabetes care in Canada.
    Blumer I
    CMAJ; 2004 Nov; 171(11):1323-4. PubMed ID: 15557569
    [No Abstract]   [Full Text] [Related]  

  • 46. Paying for population health care: the link between reimbursement models and quality health care.
    Tumerman M
    WMJ; 2007 Apr; 106(2):56-7. PubMed ID: 17479819
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of payment for performance in primary care: qualitative interview study.
    Maisey S; Steel N; Marsh R; Gillam S; Fleetcroft R; Howe A
    J Health Serv Res Policy; 2008 Jul; 13(3):133-9. PubMed ID: 18573761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Type 2 diabetics: are they getting adequate care in general practice?
    Farham B
    S Afr Med J; 2005 Sep; 95(9):672. PubMed ID: 16327922
    [No Abstract]   [Full Text] [Related]  

  • 49. Smoking cessation in disadvantaged estates in the North East.
    Lowry R; O'Farrell A; Bedford D; Eldin N
    Ir Med J; 2008; 101(10):319. PubMed ID: 19205148
    [No Abstract]   [Full Text] [Related]  

  • 50. Bupropion for smokers. Where are practices supposed to find money for bupropion?
    Vautrey R
    BMJ; 2001 Feb; 322(7283):432-3. PubMed ID: 11179167
    [No Abstract]   [Full Text] [Related]  

  • 51. The 2005 British Columbia Smoking Cessation Mass Media Campaign and short-term changes in smoking.
    Gagné L
    J Public Health Manag Pract; 2007; 13(3):296-306. PubMed ID: 17435497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Getting rewards for your results: pay-for-performance programs.
    Endsley S; Kirkegaard M; Baker G; Murcko AC
    Fam Pract Manag; 2004 Mar; 11(3):45-50. PubMed ID: 15045878
    [No Abstract]   [Full Text] [Related]  

  • 53. Smoking among diabetes patients in Yogyakarta, Indonesia: cessation efforts are urgently needed.
    Padmawati RS; Ng N; Prabandari YS; Nichter M
    Trop Med Int Health; 2009 Apr; 14(4):412-9. PubMed ID: 19228351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Smoking cessation must be professionalized].
    Kunze M; Groman E
    Wien Klin Wochenschr; 2006 May; 118(7-8):193-5. PubMed ID: 16794754
    [No Abstract]   [Full Text] [Related]  

  • 55. Exclusion of patients from pay-for-performance targets by English physicians.
    Doran T; Fullwood C; Reeves D; Gravelle H; Roland M
    N Engl J Med; 2008 Jul; 359(3):274-84. PubMed ID: 18635432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multifactorial intervention and mortality in type 2 diabetes.
    Schroeder SA
    N Engl J Med; 2008 May; 358(21):2292; author reply 2292-3. PubMed ID: 18499577
    [No Abstract]   [Full Text] [Related]  

  • 57. Socioeconomic deprivation, coronary heart disease prevalence and quality of care: a practice-level analysis in Rotherham using data from the new UK general practitioner Quality and Outcomes Framework.
    Strong M; Maheswaran R; Radford J
    J Public Health (Oxf); 2006 Mar; 28(1):39-42. PubMed ID: 16436452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
    Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
    Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Economic incentives and treatment quality].
    Munkerud SF
    Tidsskr Nor Laegeforen; 2010 Oct; 130(20):2030-2. PubMed ID: 20967044
    [No Abstract]   [Full Text] [Related]  

  • 60. Stop-Smoking Medication Use, Subsidization Policies, and Cessation in Canada.
    White CM; Rynard VL; Reid JL; Ahmed R; Burkhalter R; Hammond D
    Am J Prev Med; 2015 Aug; 49(2):188-98. PubMed ID: 26033348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.